CrystalGenomics, Inc. (083790.KQ)

KRW 2545.0

(0.99%)

Total Assets Summary of CrystalGenomics, Inc.

CrystalGenomics, Inc.'s latest annual total assets in 2023 was 243.11 Billion USD , down -24.64% from previous year.
CrystalGenomics, Inc.'s latest quarterly total assets in 2024 Q1 was 236.3 Billion KRW , down -2.8% from previous quarter.
CrystalGenomics, Inc. reported annual total assets of 322.61 Billion USD in 2022, down -3.1% from previous year.
CrystalGenomics, Inc. reported annual total assets of 332.92 Billion USD in 2021, up 5.04% from previous year.
CrystalGenomics, Inc. reported quarterly total assets of 237 Billion KRW for 2024 Q2, up 0.3% from previous quarter.
CrystalGenomics, Inc. reported quarterly total assets of 243.11 Billion USD for 2023 FY, down -24.64% from previous quarter.

Annual Total Assets Chart of CrystalGenomics, Inc. (2023 - 2013)

Historical Annual Total Assets of CrystalGenomics, Inc. (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	243.11 Billion USD	-24.64%
2022	322.61 Billion USD	-3.1%
2021	332.92 Billion USD	5.04%
2020	316.96 Billion USD	3102.94%
2019	9.89 Billion USD	5.87%
2018	9.34 Billion USD	0.94%
2017	9.25 Billion USD	7.67%
2016	8.59 Billion USD	6.14%
2015	8.1 Billion USD	8.07%
2014	7.49 Billion USD	8.78%
2013	6.89 Billion USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	236.3 Billion KRW	-2.8%
2024 Q2	237 Billion KRW	0.3%
2023 FY	243.11 Billion USD	-24.64%
2023 Q1	337.93 Billion USD	2073.91%
2023 Q3	333.56 Billion USD	-9.04%
2023 Q2	366.71 Billion KRW	8.52%
2023 Q4	243.11 Billion USD	-27.12%
2022 FY	322.61 Billion USD	-3.1%
2022 Q3	15.27 Billion USD	0.0%
2022 Q1	14.52 Billion USD	3.14%
2022 Q4	15.54 Billion USD	1.77%
2021 Q4	14.07 Billion USD	-3.02%
2021 FY	332.92 Billion USD	5.04%
2021 Q1	14.13 Billion USD	-2.96%
2021 Q3	14.51 Billion USD	0.0%
2020 Q1	12.9 Billion USD	1.59%
2020 Q4	14.56 Billion USD	1.0%
2020 FY	316.96 Billion USD	3102.94%
2020 Q3	14.42 Billion USD	0.0%
2019 FY	9.89 Billion USD	5.87%
2019 Q4	12.7 Billion USD	28.34%
2019 Q1	9.77 Billion USD	0.29%
2019 Q3	9.89 Billion USD	0.0%
2018 Q1	9.3 Billion USD	-1.08%
2018 FY	9.34 Billion USD	0.94%
2018 Q4	9.74 Billion USD	4.26%
2018 Q3	9.34 Billion USD	0.0%
2017 Q1	9.02 Billion USD	1.41%
2017 Q4	9.4 Billion USD	1.55%
2017 Q3	9.25 Billion USD	0.0%
2017 FY	9.25 Billion USD	7.67%
2016 Q1	8.46 Billion USD	1.17%
2016 Q3	8.59 Billion USD	0.0%
2016 Q4	8.9 Billion USD	3.52%
2016 FY	8.59 Billion USD	6.14%
2015 Q1	8.03 Billion USD	4.09%
2015 FY	8.1 Billion USD	8.07%
2015 Q4	8.36 Billion USD	3.26%
2015 Q3	8.1 Billion USD	0.0%
2014 Q1	7.37 Billion USD	4.96%
2014 FY	7.49 Billion USD	8.78%
2014 Q4	7.71 Billion USD	2.93%
2014 Q3	7.49 Billion USD	0.0%
2013 Q4	7.02 Billion USD	1.91%
2013 Q3	6.89 Billion USD	0.0%
2013 FY	6.89 Billion USD	0.0%
2013 Q1	6.78 Billion USD	1.81%
2012 Q4	6.66 Billion USD	0.0%

Peer Total Assets Comparison of CrystalGenomics, Inc.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	67.659%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-146.531%
BINEX Co., Ltd.	257.01 Billion KRW	5.407%
Bioneer Corporation	315.48 Billion KRW	22.94%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-62.693%
MEDIPOST Co., Ltd.	449.39 Billion KRW	45.901%
Helixmith Co., Ltd	227.27 Billion KRW	-6.968%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	85.911%
Medy-Tox Inc.	611.62 Billion KRW	60.251%
Peptron, Inc.	52.49 Billion KRW	-363.113%
Amicogen, Inc.	467.09 Billion KRW	47.952%
Genexine, Inc.	376.58 Billion KRW	35.442%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	-21.077%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-28.292%
ALTEOGEN Inc.	256.09 Billion KRW	5.07%
PharmaResearch Co., Ltd.	535.28 Billion KRW	54.582%
SillaJen, Inc.	76.71 Billion KRW	-216.908%
JETEMA, Co., Ltd.	252.14 Billion KRW	3.582%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-136.436%
Genomictree Inc.	132.84 Billion KRW	-83.008%
MedPacto, Inc.	80.47 Billion KRW	-202.103%
D&D Pharmatech	79.2 Billion KRW	-206.95%
EASY BIO,Inc.	172.04 Billion KRW	-41.312%
GI Innovation, Inc.	81.34 Billion KRW	-198.887%